FORTRESS BIOTECH, INC. received a stock award from CHECKPOINT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/3/2025ACC: 0001415889-25-000403
10% Owner
Since Jan 2023
+2.47M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.47M acquired
Non-Derivative Transactions2
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+81.41K
Price / share
—
Trade value
—
% of position
2.2%
12/31/2024
3.74M→3.82M
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+2.39M
Price / share
—
Trade value
—
% of position
62.5%
1/1/2025
3.82M→6.20M
Total
Net shares
+2.47M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 12/31/2024 | A · Award | +81.41K | — | — | 2.2% | 3.74M | 3.82M |
| COMMON STOCK, PAR VALUE $0.0001 Direct | 1/1/2025 | A · Award | +2.39M | — | — | 62.5% | 3.82M | 6.20M |
| Total | +2.47M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported